NO972278L - Fluorerte vitamin D3-analoger - Google Patents
Fluorerte vitamin D3-analogerInfo
- Publication number
- NO972278L NO972278L NO972278A NO972278A NO972278L NO 972278 L NO972278 L NO 972278L NO 972278 A NO972278 A NO 972278A NO 972278 A NO972278 A NO 972278A NO 972278 L NO972278 L NO 972278L
- Authority
- NO
- Norway
- Prior art keywords
- double bond
- hydrogen
- bond
- alkyl
- independently
- Prior art date
Links
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 14
- 239000001257 hydrogen Substances 0.000 abstract 8
- 150000002431 hydrogen Chemical class 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Nye fluorerte vitamin D3-analoger med formel %6 24k2>R3, l\ OH hvor: X er (H,H) eller =CH2; Ri og Rj er, uavhengig av hverandre, hydrogen, (Ci-C4)-alkyl eller fluor- alkyl, eller R^ og R2 sammen med C-20 danner (Cj-Cg)- cykloalkyl eller cyklofluoralkyl, eller R^ og R2 sammen danner =CH2; R3 og R4 er, uavhengig av hver- andre, (C]^-C4)-alkyl eller fluoralkyl, eller R3 og R4 saiTimen med C-25 danner (C3-C9)-cykloalkyl eller cyklofluoralkyl; A er en enkeltbinding eller en dobbeltbinding; og B er en dobbeltbinding eller en trippelbinding; unntatt: (i) når X er =CH2, R3 og R4 begge er CF3, A er en dobbeltbinding og en av R^^ og Rj er hydrogen, da kan den andre av R^ og Rj ikke være CH3; (ii) når X er =CH2, R3 og R4 begge er (C^- Cj)-alkyl, A er en dobbeltbinding og Rj er hydrogen, da kan R^ ikke være CH3; (iii) når X er =CH2, R3 og R4 begge er (CiL-C4)-alkyl, A er en dobbeltbinding og R^ er hydrogen, da kan R2 ikke være CH3; (iv) når X er =CH2, en av R3 og R4 er CF3, A er en dobbelt- binding. Ri er CH3 og Rj er hydrogen, da kan den andre av R3 og R4 ikke være CH3; og (v) når X er (H,H), R3 og R4 begge er CF3, A er en dobbeltbinding, B er en trippelbinding og Rj er hydrogen, da kan R^ ikke være CH3; og forbindelsene i formel I ovenfor hvor: X er (H,H) eller =CH2; R-^ og R2 er, uavhengig av hverandre, hydrogen, (Ci-C4)-alkyl eller fluor- alkyl, eller R^ og Rj sammen med C-20 danner (C3-Cg)- cykloalkyl eller cyklofluoralkyl, eller R^ og Rj sammen c-:inner =CH2; R3 og R^ er, uavhengig av hver- andre, ( 2^^-04)-alkyl eller fluoralkyl, eller R3 og R4 sammen med C-25 danner (C3-C9)-cykloalkyl eller cyklofluoralkyl; A er en enkeltbinding eller en dobb'?ltbinding; og B er en dobbeltbinding eller en trippelbinding; unntatt hvor R3 og R4 begge er CF3 og A er en dobbeltbinding og B er en trippelbinding og R2 er hydrogen, da kan R^ ikke være CH3, er nyttige ved behandling av osteoporose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1821996P | 1996-05-23 | 1996-05-23 | |
US3990197P | 1997-03-19 | 1997-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972278D0 NO972278D0 (no) | 1997-05-20 |
NO972278L true NO972278L (no) | 1997-11-24 |
Family
ID=26690870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972278A NO972278L (no) | 1996-05-23 | 1997-05-20 | Fluorerte vitamin D3-analoger |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0808832B1 (no) |
JP (1) | JP2859248B2 (no) |
KR (1) | KR100253961B1 (no) |
CN (1) | CN100402497C (no) |
AR (1) | AR007776A1 (no) |
AT (1) | ATE238278T1 (no) |
AU (1) | AU733970B2 (no) |
BR (1) | BR9703385A (no) |
CA (1) | CA2205315C (no) |
CO (1) | CO4940503A1 (no) |
CZ (1) | CZ157797A3 (no) |
DE (1) | DE69721123T2 (no) |
DK (1) | DK0808832T3 (no) |
ES (1) | ES2195049T3 (no) |
HR (1) | HRP970272A2 (no) |
HU (1) | HUP9700928A3 (no) |
IL (1) | IL120844A0 (no) |
MA (1) | MA24250A1 (no) |
NO (1) | NO972278L (no) |
NZ (1) | NZ314840A (no) |
PE (1) | PE66798A1 (no) |
PL (1) | PL320130A1 (no) |
PT (1) | PT808832E (no) |
SG (1) | SG70010A1 (no) |
TR (1) | TR199700416A2 (no) |
YU (1) | YU20097A (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
DE19935771A1 (de) | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
WO2002013832A1 (fr) * | 2000-08-17 | 2002-02-21 | Chugai Seiyaku Kabushiki Kaisha | Agent therapeutique destine au traitement de l'osteoporose |
MXPA04002640A (es) * | 2001-09-21 | 2004-06-07 | Hoffmann La Roche | Esteres de analogos de 3-desoxi-vitamina d3. |
AU2004203436A1 (en) | 2003-09-24 | 2005-04-14 | Bioxell Spa | Compound and use in treatment |
CN101106985A (zh) * | 2004-09-24 | 2008-01-16 | 拜奥艾克塞尔股份公司 | 20-环烷基,26,27-烷基/卤代烷基维生素d3化合物及其使用方法 |
EP1879596A4 (en) * | 2005-03-23 | 2009-01-21 | Bioxell Spa | 20 ALKYL, GEMINI VITAMIN D3 COMPOUNDS AND METHOD OF USE THEREOF |
ES2541719T3 (es) * | 2010-10-25 | 2015-07-24 | Teijin Pharma Limited | Derivado de 23-ino-vitamina D3 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4141746A1 (de) * | 1991-12-13 | 1993-06-17 | Schering Ag | 20-methyl-substituierte vitamin d-derivate |
DE4220757A1 (de) * | 1992-06-24 | 1994-01-05 | Schering Ag | Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
US5384314B1 (en) * | 1994-03-11 | 1997-08-05 | Hoffmann La Roche | 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol |
WO1997016193A1 (en) * | 1995-10-27 | 1997-05-09 | F. Hoffmann-La Roche Ag | Pharmaceutical composition for treating osteoporosis |
-
1997
- 1997-05-12 SG SG1997001484A patent/SG70010A1/en unknown
- 1997-05-14 AT AT97107868T patent/ATE238278T1/de not_active IP Right Cessation
- 1997-05-14 DK DK97107868T patent/DK0808832T3/da active
- 1997-05-14 EP EP97107868A patent/EP0808832B1/en not_active Expired - Lifetime
- 1997-05-14 PT PT97107868T patent/PT808832E/pt unknown
- 1997-05-14 ES ES97107868T patent/ES2195049T3/es not_active Expired - Lifetime
- 1997-05-14 CA CA002205315A patent/CA2205315C/en not_active Expired - Fee Related
- 1997-05-14 DE DE69721123T patent/DE69721123T2/de not_active Expired - Lifetime
- 1997-05-16 PE PE1997000387A patent/PE66798A1/es not_active Application Discontinuation
- 1997-05-16 NZ NZ314840A patent/NZ314840A/en unknown
- 1997-05-16 IL IL12084497A patent/IL120844A0/xx unknown
- 1997-05-20 HR HR60/039,901A patent/HRP970272A2/xx not_active Application Discontinuation
- 1997-05-20 NO NO972278A patent/NO972278L/no unknown
- 1997-05-20 YU YU20097A patent/YU20097A/sh unknown
- 1997-05-21 MA MA24631A patent/MA24250A1/fr unknown
- 1997-05-21 HU HU9700928A patent/HUP9700928A3/hu unknown
- 1997-05-21 AR ARP970102159A patent/AR007776A1/es active IP Right Grant
- 1997-05-22 PL PL97320130A patent/PL320130A1/xx unknown
- 1997-05-22 CZ CZ971577A patent/CZ157797A3/cs unknown
- 1997-05-22 CN CNB971134324A patent/CN100402497C/zh not_active Expired - Fee Related
- 1997-05-22 JP JP9131810A patent/JP2859248B2/ja not_active Expired - Fee Related
- 1997-05-22 AU AU23576/97A patent/AU733970B2/en not_active Ceased
- 1997-05-22 CO CO97028096A patent/CO4940503A1/es unknown
- 1997-05-22 KR KR1019970020029A patent/KR100253961B1/ko not_active IP Right Cessation
- 1997-05-23 TR TR97/00416A patent/TR199700416A2/xx unknown
- 1997-05-23 BR BR9703385A patent/BR9703385A/pt not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA842185B (en) | New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof | |
MY132867A (en) | Acid-stable borates for photopolymerization | |
ATE133661T1 (de) | Fluorierte kohlenwasserstoffderivate, ihre verwendung in kosmetischen zusammensetzungen, verfahren zu ihrer herstellung und sie enthaltende kosmetische zusammensetzungen | |
MY113419A (en) | Mixtures of mono-and bis-resorclnyl-2-nydroxyphenyltriazine uv absorbers and their use as stabilizers for organic materials | |
NO972278L (no) | Fluorerte vitamin D3-analoger | |
ID18576A (id) | Senyawa antara untuk membuat turunan-turunan steroid yang digunakan dalam pengobatan hipertropi prostatik dan pembuatannya | |
YU47298B (sh) | Derivati 16-dehidro-vitamina d3 | |
ES8303395A1 (es) | "procedimiento de preparar compuestos benzoxepinicos y analogos". | |
GB2283016A (en) | Scavenging of hydrogen sulphide | |
IL83141A (en) | Solutions of oxazophosphorins having improved stability and their preparation | |
AU1706495A (en) | Stabilizer mixture made up of chromane derivatives, organic phosphites or phosphonites and amines | |
GB1477293A (en) | Tetralone and indanone derivatives and process for their preparations | |
AU6559994A (en) | Stable moulding or spinning compound containing cellulose | |
EA199800468A1 (ru) | 25-гидрокси-16-ен-26,27-бисгомохолекальциферолы | |
JPS5735506A (en) | Bleaching cosmetic | |
NO940113L (no) | Syntese av 2-fenyl-substituerte 1,3-propandioler | |
FI832007L (fi) | En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel | |
AU683148B2 (en) | Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases | |
HU9502179D0 (en) | Piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them | |
ES2150564T3 (es) | Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno. | |
FI925618A0 (fi) | Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar | |
JPS5716852A (en) | Nitrile derivative, its preparation, and fibrosis suppressing agent containing the same | |
AU3093689A (en) | Adhesive | |
SU1837613A1 (ru) | Гидрофобизатор для обработки бетона | |
US4268669A (en) | 9-Deoxy-9-methylene-5,6-didehydro-PGF1 amides |